Discovering the anticancer potential of non-oncology drugs by systematic viability profiling

被引:505
作者
Corsello, Steven M. [1 ,2 ,3 ]
Nagari, Rohith T. [1 ]
Spangler, Ryan D. [1 ]
Rossen, Jordan [1 ,6 ]
Kocak, Mustafa [1 ]
Bryan, Jordan G. [1 ]
Humeidi, Ranad [1 ]
Peck, David [1 ]
Wu, Xiaoyun [1 ]
Tang, Andrew A. [1 ]
Wang, Vickie M. [1 ]
Bender, Samantha A. [1 ]
Lemire, Evan [1 ]
Narayan, Rajiv [1 ]
Montgomery, Philip [1 ]
Ben-David, Uri [1 ,7 ]
Garvie, Colin W. [1 ]
Chen, Yejia [1 ]
Rees, Matthew G. [1 ]
Lyons, Nicholas J. [1 ]
McFarland, James M. [1 ]
Wong, Bang T. [1 ]
Wang, Li [1 ,8 ]
Dumont, Nancy [1 ]
O'Hearn, Patrick J. [1 ,9 ]
Stefan, Eric [10 ]
Doench, John G. [1 ]
Harrington, Caitlin N. [1 ]
Greulich, Heidi [1 ]
Meyerson, Matthew [1 ,2 ,3 ]
Vazquez, Francisca [1 ]
Subramanian, Aravind [1 ]
Roth, Jennifer A. [1 ]
Bittker, Joshua A. [1 ,11 ]
Boehm, Jesse S. [1 ]
Mader, Christopher C. [1 ,12 ]
Tsherniak, Aviad [1 ]
Golub, Todd R. [1 ,3 ,4 ,5 ]
机构
[1] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[5] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
[6] Duke Univ, Durham, NC USA
[7] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Tel Aviv, Israel
[8] 10x Genomics, Pleasanton, CA USA
[9] Relay Therapeut, Cambridge, MA USA
[10] Biogen, Cambridge, MA USA
[11] Vertex Pharmaceut, Boston, MA USA
[12] Flatiron Hlth, New York, NY USA
基金
美国国家卫生研究院;
关键词
CANCER; IDENTIFICATION; DISULFIRAM; SENSITIVITY; RESISTANCE; LANDSCAPE;
D O I
10.1038/s43018-019-0018-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anticancer uses of non-oncology drugs have occasionally been found, but such discoveries have been serendipitous. We sought to create a public resource containing the growth-inhibitory activity of 4,518 drugs tested across 578 human cancer cell lines. We used PRISM (profiling relative inhibition simultaneously in mixtures), a molecular barcoding method, to screen drugs against cell lines in pools. An unexpectedly large number of non-oncology drugs selectively inhibited subsets of cancer cell lines in a manner predictable from the molecular features of the cell lines. Our findings include compounds that killed by inducing phosphodiesterase 3A-Schlafen 12 complex formation, vanadium-containing compounds whose killing depended on the sulfate transporter SLC26A2, the alcohol dependence drug disulfiram, which killed cells with low expression of metallothioneins, and the anti-inflammatory drug tepoxalin, which killed via the multidrug resistance protein ATP-binding cassette subfamily B member 1 (ABCB1). The PRISM drug repurposing resource () is a starting point to develop new oncology therapeutics, and more rarely, for potential direct clinical translation.
引用
收藏
页码:235 / +
页数:25
相关论文
共 56 条
[1]   TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types [J].
Aben, Nanne ;
Vis, Daniel J. ;
Michaut, Magali ;
Wesseis, Lodewyk F. A. .
BIOINFORMATICS, 2016, 32 (17) :413-420
[2]   Genetic effects on gene expression across human tissues [J].
Aguet, Francois ;
Brown, Andrew A. ;
Castel, Stephane E. ;
Davis, Joe R. ;
He, Yuan ;
Jo, Brian ;
Mohammadi, Pejman ;
Park, Yoson ;
Parsana, Princy ;
Segre, Ayellet V. ;
Strober, Benjamin J. ;
Zappala, Zachary ;
Cummings, Beryl B. ;
Gelfand, Ellen T. ;
Hadley, Kane ;
Huang, Katherine H. ;
Lek, Monkol ;
Li, Xiao ;
Nedzel, Jared L. ;
Nguyen, Duyen Y. ;
Noble, Michael S. ;
Sullivan, Timothy J. ;
Tukiainen, Taru ;
MacArthur, Daniel G. ;
Getz, Gad ;
Management, Nih Program ;
Addington, Anjene ;
Guan, Ping ;
Koester, Susan ;
Little, A. Roger ;
Lockhart, Nicole C. ;
Moore, Helen M. ;
Rao, Abhi ;
Struewing, Jeffery P. ;
Volpi, Simona ;
Collection, Biospecimen ;
Brigham, Lori E. ;
Hasz, Richard ;
Hunter, Marcus ;
Johns, Christopher ;
Johnson, Mark ;
Kopen, Gene ;
Leinweber, William F. ;
Lonsdale, John T. ;
McDonald, Alisa ;
Mestichelli, Bernadette ;
Myer, Kevin ;
Roe, Bryan ;
Salvatore, Michael ;
Shad, Saboor .
NATURE, 2017, 550 (7675) :204-+
[3]  
ALLEY MC, 1988, CANCER RES, V48, P589
[4]  
[Anonymous], AN READ STAND TCGA D, DOI 10.7908/C11G0KM9
[5]  
ARGENTIERI DC, 1994, J PHARMACOL EXP THER, V271, P1399
[6]   The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [J].
Barretina, Jordi ;
Caponigro, Giordano ;
Stransky, Nicolas ;
Venkatesan, Kavitha ;
Margolin, Adam A. ;
Kim, Sungjoon ;
Wilson, Christopher J. ;
Lehar, Joseph ;
Kryukov, Gregory V. ;
Sonkin, Dmitriy ;
Reddy, Anupama ;
Liu, Manway ;
Murray, Lauren ;
Berger, Michael F. ;
Monahan, John E. ;
Morais, Paula ;
Meltzer, Jodi ;
Korejwa, Adam ;
Jane-Valbuena, Judit ;
Mapa, Felipa A. ;
Thibault, Joseph ;
Bric-Furlong, Eva ;
Raman, Pichai ;
Shipway, Aaron ;
Engels, Ingo H. ;
Cheng, Jill ;
Yu, Guoying K. ;
Yu, Jianjun ;
Aspesi, Peter, Jr. ;
de Silva, Melanie ;
Jagtap, Kalpana ;
Jones, Michael D. ;
Wang, Li ;
Hatton, Charles ;
Palescandolo, Emanuele ;
Gupta, Supriya ;
Mahan, Scott ;
Sougnez, Carrie ;
Onofrio, Robert C. ;
Liefeld, Ted ;
MacConaill, Laura ;
Winckler, Wendy ;
Reich, Michael ;
Li, Nanxin ;
Mesirov, Jill P. ;
Gabriel, Stacey B. ;
Getz, Gad ;
Ardlie, Kristin ;
Chan, Vivien ;
Myer, Vic E. .
NATURE, 2012, 483 (7391) :603-607
[7]   An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules [J].
Basu, Amrita ;
Bodycombe, Nicole E. ;
Cheah, Jaime H. ;
Price, Edmund V. ;
Liu, Ke ;
Schaefer, Giannina I. ;
Ebright, Richard Y. ;
Stewart, Michelle L. ;
Ito, Daisuke ;
Wang, Stephanie ;
Bracha, Abigail L. ;
Liefeld, Ted ;
Wawer, Mathias ;
Gilbert, Joshua C. ;
Wilson, Andrew J. ;
Stransky, Nicolas ;
Kryukov, Gregory V. ;
Dancik, Vlado ;
Barretina, Jordi ;
Garraway, Levi A. ;
Hon, C. Suk-Yee ;
Munoz, Benito ;
Bittker, Joshua A. ;
Stockwell, Brent R. ;
Khabele, Dineo ;
Stern, Andrew M. ;
Clemons, Paul A. ;
Shamji, Alykhan F. ;
Schreiber, Stuart L. .
CELL, 2013, 154 (05) :1151-1161
[8]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[9]   Genetic and transcriptional evolution alters cancer cell line drug response [J].
Ben-David, Uri ;
Siranosian, Benjamin ;
Ha, Gavin ;
Tang, Helen ;
Oren, Yaara ;
Hinohara, Kunihiko ;
Strathdee, Craig A. ;
Dempster, Joshua ;
Lyons, Nicholas J. ;
Burns, Robert ;
Nag, Anwesha ;
Kugener, Guillaume ;
Cimini, Beth ;
Tsvetkov, Peter ;
Maruvka, Yosef E. ;
O'Rourke, Ryan ;
Garrity, Anthony ;
Tubelli, Andrew A. ;
Bandopadhayay, Pratiti ;
Tsherniak, Aviad ;
Vazquez, Francisca ;
Wong, Bang ;
Birger, Chet ;
Ghandi, Mahmoud ;
Thorner, Aaron R. ;
Bittker, Joshua A. ;
Meyerson, Matthew ;
Getz, Gad ;
Beroukhim, Rameen ;
Golub, Todd R. .
NATURE, 2018, 560 (7718) :325-+
[10]  
Birger C, 2017, FIRECLOUD SCALABLE C, DOI 10.1101/209494